Vickers, M. A., Wilkie, G. M., Robinson, N., Rivera, N., Haque, T., Crawford, D. H., Barry, J., Fraser, N., Turner, D. M., Robertson, V., Dyer, P., Flanagan, P., Newlands, H. R., Campbell, J., & Turner, M. L. (n.d.). establishment and operation of a Good Manufacturing Practice‐compliant allogeneic Epstein‐Barr virus (EBV)‐specific cytotoxic cell bank for the treatment of EBV‐associated lymphoproliferative disease. British journal of haematology, 167, 402–410. http://access.bl.uk/ark:/81055/vdc_100025055956.0x000025